Cytomab 500 mg Injection
$436,77
$340,68
Cytomab 500 mg Injection is a powerful monoclonal antibody therapy designed to address various immune-related disorders and certain malignancies. Primarily, it plays a crucial role in the treatment of specific types of cancers, such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia, by targeting and inhibiting the growth of cancer cells. This innovative treatment works by binding to specific proteins on the surface of abnormal cells, effectively marking them for destruction by the immune system. Patients receiving Cytomab should be aware of potential side effects, including infusion reactions and increased risk of infections, necessitating close monitoring by healthcare professionals. Additionally, it’s important to disclose any pre-existing conditions or medications to your doctor prior to treatment to avoid complications. With its targeted approach, Cytomab represents a significant advancement in oncology, providing hope for many battling these challenging diseases. Always consult your healthcare provider for personalized advice and information regarding this medication to ensure safe and effective use.
數量
Active Pharmaceutical Ingredient
Uses
• Cytomab 500 mg injection is primarily used in the treatment of Non-Hodgkin lymphoma (NHL). This medication helps target and eliminate cancerous cells, which can significantly improve patient outcomes. It is often administered as part of a comprehensive treatment plan tailored to individual needs. Many patients benefit from this targeted therapy approach, which aims to reduce tumor size and manage symptoms effectively.
• In addition to its application in NHL, Cytomab 500 mg injection is utilized for managing rheumatoid arthritis. This condition involves chronic inflammation of the joints, leading to pain and disability. Cytomab 500 mg injection works by modulating the immune response, which can help alleviate symptoms and improve joint function. Patients receiving this treatment often report enhanced quality of life and greater mobility.
• Cytomab 500 mg injection is also effective in treating chronic lymphocytic leukaemia (CLL), a type of blood cancer. By targeting the specific cells associated with CLL, this medication aids in controlling the progression of the disease. Patients undergoing treatment with Cytomab 500 mg injection typically experience a decrease in disease-related symptoms and an improved overall prognosis. This targeted approach is integral to modern oncology.
• Furthermore, Cytomab 500 mg injection is indicated for conditions such as granulomatosis with polyangiitis and microscopic polyangiitis. These autoimmune disorders can lead to severe inflammation and damage to blood vessels. The use of Cytomab 500 mg injection helps to modulate the immune system, reducing inflammation and preventing further complications. This therapeutic strategy is crucial in managing these complex conditions effectively.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Cytomab 500 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Cytomab 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Cytomab 500 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Cytomab 500 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Cytomab 500 Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Cytomab 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Cytomab 500 mg Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Cytomab 500 mg. Please consult your doctor.
• Kidney: Cytomab 500 Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Cytomab 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Cytomab 500 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Cytomab 500 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Cytomab 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.